Comparison of the metastasis-inducing protein S100A4 (p9Ka) with other prognostic markers in human breast cancer

International Journal of Cancer

Volumn 86, Issue 3, 2000, Pages 198-208

  Platt Higgins, Angela M ^a   Renshaw, Christine A ^a   West, Christopher R ^a   Winstanley, John H R ^b   Rudland, Suzete De Silva ^a   Barraclough, Roger ^a   Rudland, Philip S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN S 100; EPIDERMAL GROWTH FACTOR RECEPTOR 2; S100A4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; BREAST; BREAST TUMOR; CANCER STAGING; CHEMISTRY; COMPARATIVE STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SURVIVAL; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; S100 PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034688926     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l     Document Type: Article

References (22)

1. ALTMAN, D.G., Practical statistics for medical research, pp 403-405, Chapman and Hall, London (1991).
2. AMBARTSUMIAN, N., GRIGORIAN, M., LARSEN, F., KARLSTROM, O., SIDENIUS, N., RYGAARD, J., GEORGIEV, G. and LUKANIDIN, E., Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene, 13, 1621-1630 (1996).
3. BARNES, D.M., DUBLIN, E.A., FISHER, C.J., LEVISON, D.A. and MILLIS, R., Immunohistochemical detection of p53 protein in mammary carcinoma. An important new independent indicator of prognosis? Hum. Pathol., 24, 469-476 (1993).
4. DAVIES, B.R., DAVIES, M.P.A., GIBBS, F.E.M., BARRACLOUGH, R. and RUDLAND, P.S., Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ ras-1. Oncogene, 8, 999-1008 (1993).
5. DAVIES, M.P.A., RUDLAND, P.S., ROBERTSON, L., PARRY, E., JOLICOEUR, P. and BARRACLOUGH, R., Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumors. Oncogene, 13, 1631-1637 (1996).
6. GIBBS, F.E.M., BARRACLOUGH, R., PLATT-HIGGINS, A., RUDLAND, P.S., WILKINSON, M.C. and PARRY, E., Immunocytochemical distribution of the calcium-binding protein p9Ka in normal rat tissues: variation in the cellular location in different tissues. J. Histochem. Cytochem., 43, 169-180 (1995).
7. HORIGUCHI, J., IINO, Y. and TAKEI, H., Expression of pS2 estrogen-inducible protein in primary breast cancer. Oncology, 53, 12-15 (1996).
8. KAMBY, C., The pattern of metastasis in human breast cancer: methodological aspects and influence of prognostic factors. Cancer Treat. Rev., 17, 37-61 (1990).
9. LEMOINE, N.R., BARNES, D.M., HOLLYWOOD, D.P., HUGHES, C.M., SMITH, P., DUBLIN, E., PRIGENT, S.A., GULLICK, W.J. and HURST, H.C., Expression of c-erbB-3 gene product in breast cancer. Brit. J. Cancer, 66, 1116-1121 (1992).
10. LLOYD, B., PLATT-HIGGINS, A., RUDLAND, P.S. and BARRACLOUGH, R., Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumor cells. Oncogene, 17, 465-473 (1998).
11. NIKITENKO, L.L., LLOYD, B.H., RUDLAND, P.S., FEAR, S. and BARRACLOUGH, R., In situ hybridization of S100A4 (p9Ka) in human breast cancer. Int. J. Cancer (2000). (In press).
12. RENSHAW, C.A., An investigation of prognostic factors in primary breast cancer and their relationship to long term prognosis. M. Phil. Thesis, University of Liverpool, Liverpool (1997).
13. RIDINGER, K., ILG, E.C., NIGGLI, F.K., HEIZMANN, C.W. and SCHÄFER, B.W., Clustered organisation of S100 genes in human and mouse. Biochim. biophys. Acta, 1448, 254-263 (1998).
14. ROBERTSON, J.F.R., BATES, K., PEARSON, D., BLAMEY, R.W. and NICOLSON, R.I., Comparison of two oestrogen receptor assays in the prediction of clinical course of patients with advanced breast cancer. Brit. J. Cancer, 65, 727-730 (1992).
15. SLAMON, D.J., CLARK, G.M., WONG, G.G., LEVIN, W.J., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-187 (1987).
16. SPYRATOS, F., HACENE, K., TUBIANA-HULIN, M., PALLUD, C. and BRUNET, M., Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. Europ. J. clin. Oncol., 25, 1233-1240 (1989).
17. TAKENAGA, K., NAKAMURA, Y., ENDO, H. and SAKIYAMA, S., Involvement of S100-calcium binding protein pEL98 (or mts-1) in cell motility and tumor cell invasion. Japn. J. Cancer Res., 85, 831-839 (1994).
18. TAKENAGA, K., NAKANISHI, H., WADA, K., SUZUKI, M., MATSUZAKI, O., MATSUURA, A. and ENDO, H., Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin. Cancer Res., 3, 2309-2316 (1997).
19. TULCHINSKY, E., KRAMEROV, H., FORD, H.L., RESHETNYAK, E., LUKANIDIN, E. and ZAIN, S., Characterisation of a positive regulatory element in the mts-1 gene. Oncogene, 8, 79-86 (1993).
20. WARBURTON, M.J., MITCHELL, D., ORMEROD, E.J. and RUDLAND, P.S., Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating and involuting rat mammary gland. J. Histochem. Cytochem., 30, 667-676 (1982).
21. WINSTANLEY, J.H.R., COOKE, T., MURRAY, G.D., PLATT-HIGGINS, A.M., GEORGE, W.D., HOLT, S.M., MYSKOV, M., SPEDDING, A., BARRACLOUGH, R. and RUDLAND, P.S., The long term prognostic significance of c-erbB-2 in primary breast cancer. Brit. J. Cancer, 63, 447-450 (1991).
22. WINSTANLEY, J.H.R., LEINSTER, S.J., COOKE, T.G., WESTLEY, B.R., PLATT-HIGGINS, A.M. and RUDLAND, P.S., Prognostic significance of cathepsin-D in patients with breast cancer. Brit. J. Cancer, 67, 762-772 (1993).